Physician

Christopher Michael Bair, M.D.

According to 2025 Medicare claims, Christopher Bair, M.D. (NPI: 1245763390) practices ophthalmology in the Canton-Massillon, OH market, with the plurality of this provider's patient population coming from Stark, OH. This provider's primary affiliated billing organization is VITREO-RETINAL CONSULTANTS, INC. (NPI: 1750347662; TIN: 341390523) and primary practice location at 44718-3619. Bair is affiliated with the IHC Quality Partners, LLC (ACO ID: A2833), participating under the MSSP model.

Bair's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 834 traditional Medicare patients, billed 26,092 HCPCS/CPT codes, and received $1,849,524 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 673 prescription claims across 253 beneficiaries totaling $23,944 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 43 records totaling $992. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $7,620 to $23,944. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$925K$1.8M2021 Medicare payment: $7,165 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $22,068 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $462,953 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,849,524 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
20215183$7,165
2022164284$22,068
20234915,587$462,953
202483426,092$1,849,524

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$48K$97K2019 Drug cost: $7,620 (USD; Tot_Drug_Cst)2020 Drug cost: $1,407 (USD; Tot_Drug_Cst)2021 Drug cost: $3,974 (USD; Tot_Drug_Cst)2022 Drug cost: $20,259 (USD; Tot_Drug_Cst)2023 Drug cost: $96,901 (USD; Tot_Drug_Cst)2024 Drug cost: $23,944 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
201974195$7,620
20202032$1,407
202162124$3,974
2022140357$20,259
2023157364$96,901
2024253673$23,944

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more336712$98
92014Established patient complete exam of visual system361537$85
67028Injection of drug into eye4371,300$85
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more212318$58
92134Imaging of retina7531,818$28

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1957,233$7,928
Ketorolac TromethamineKetorolac Tromethamine1013,742$2,610
Brimonidine TartrateBrimonidine Tartrate462,938$1,163
Atropine SulfateAtropine Sulfate251,230$915
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha52820$540

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.43$992Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Christopher Michael Bair, M.D.?

Tedicare shows public-source Medicare data for Christopher Michael Bair, M.D. (NPI 1245763390), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Christopher Michael Bair, M.D. have ACO affiliation data?

Christopher Michael Bair, M.D. is shown with ACO affiliation data for IHC Quality Partners, LLC (MSSP, ACO ID A2833).

What billing organization is linked to Christopher Michael Bair, M.D.?

Christopher Michael Bair, M.D. is linked to VITREO-RETINAL CONSULTANTS, INC. (billing NPI 1750347662) in the available physician profile data.

Does Christopher Michael Bair, M.D. have Open Payments data?

Christopher Michael Bair, M.D. has 43 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.